[1]赵佳慧,余 雯.乙型肝炎肝硬化患者血清miR-25-3p 和IBSP 表达及临床意义[J].现代检验医学杂志,2022,37(04):96-101.[doi:10.3969/j.issn.1671-7414.2022.04.019]
　ZHAO Jia-hui,YU Wen.Expression and Clinical Significance of Serum miR-25-3p and IBSP in Patients with Hepatitis B Cirrhosis[J].Journal of Modern Laboratory Medicine,2022,37(04):96-101.[doi:10.3969/j.issn.1671-7414.2022.04.019]
点击复制

乙型肝炎肝硬化患者血清miR-25-3p 和IBSP 表达及临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年04期
页码:
96-101
栏目:
论著
出版日期:
2022-07-15

文章信息/Info

Title:
Expression and Clinical Significance of Serum miR-25-3p and IBSP in Patients with Hepatitis B Cirrhosis
文章编号:
1671-7414（2022）04-096-06
作者:
赵佳慧1; 余 雯2
1．南通市第六人民医院检验科，江苏南通 226001；2．南通市崇川区疾病预防控制中心检验科，江苏南通 226001
Author(s):
ZHAO Jia-hui1; YU Wen2
1. Department of Clinical Laboratory,the Sixth People’s Hospital of Nantong, Jiangsu Nantong 226001,China;2.Department of Clinical Laboratory, Chongchuan Center for Disease Control and Prevention of Nantong, Jiangsu Nantong 226001,China
关键词:
乙肝肝炎; 肝硬化; 微小核糖核酸-25-3p; 整合素结合唾液蛋白（IBSP）
分类号:
R512.62；R575.2；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.04.019
文献标志码:
A
摘要:
目的 研究乙型肝炎肝硬化患者血清微小核糖核酸（miRNA，miR）-25-3p 和整合素结合唾液蛋白(integrinbinding sialoprotein，IBSP) 表达及临床意义。方法 选取2018 年5 月～ 2019 年5 月南通市第六人民医院诊治的乙型肝炎肝硬化患者120 例为肝硬化组，并将其分为肝硬化失代偿并发腹腔积液组（47 例）和非肝硬化失代偿并发腹腔积液组（73例），以同期诊治的慢性乙型肝炎患者80 例为肝炎组，健康体检者60 例为对照组。应用酶联免疫吸附法检测各组血清IBSP 表达，荧光定量PCR 检测各组血清miR-25-3p 的表达。比较肝硬化组不同临床特征患者血清miR-25-3p 和IBSP 水平差异。Pearson 线性相关分析血清miR-25-3p 和IBSP 与肝功能评分的相关性。多因素Logistic 回归分析影响肝硬化失代偿并发腹腔积液的危险因素。受试者工作曲线（ROC）分析miR-25-3p 和IBSP 及联合检测对肝硬化失代偿并发腹腔积液的诊断价值。结果 肝硬化组、肝炎组及对照组血清miR-25-3p 水平分别为5.22±0.41，1.16±0.34 和0.92±0.32，IBSP 蛋白水平分别为9.34±1.28ng/ml, 3.15±0.37ng/ml 和1.02±0.30ng/ml。肝硬化组血清miR-25-3p 和IBSP 蛋白明显高于肝炎组（t=73.327, 42.067）及对照组（t=4.238, 34.486），差异均有统计学意义（均P ＜ 0.05）。肝硬化组患者血清miR-25-3p 和IBSP 蛋白表达水平与肝纤维化、消化道出血及腹腔积液有关（t=10.194 ～ 34.744, 均P ＜ 0.05）。肝硬化组患者血清miR-25-3p 和IBSP 蛋白表达与清蛋白-胆红素评分（albumin-bilirubin, ALBI）、终末期肝病模型评分（modelfor end-stage liver disease, MELD）、肝硬化Child -Pugh 评分均呈明显正相关（r=0.457 ～ 0.584，均P ＜ 0.05）。多因素Logistic 回归分析结果血清miR-25-3p 升高（OR:1.202,95%CI：1.059 ～ 1.642）,IBSP 升高（OR:1.229, 95%CI：1.081 ～ 1.719）是肝硬化失代偿并发腹腔积液的独立危险因素。ROC 曲线显示，miR-25-3p 和IBSP 联合诊断肝硬化失代偿及并发腹腔积液的曲线下面积（AUC）大于miR-25-3p 和IBSP 单独诊断(Z=3.727，4.163，均P=0.000)。结论 乙型肝炎肝硬化患者血清中miR-25-3p 和IBSP 蛋白水平升高，二者联合检测对乙型肝炎肝硬化失代偿并发腹腔积液具有较高诊断价值。
Abstract:
Objective To study the expression and clinical significance of serum microRNA (miR) -25-3p and integrin binding salivary protein (IBSP) in patients with hepatitis B cirrhosis. Methods 120 patients with hepatitis B cirrhosis treated in the Sixth People’s Hospital of Nantong from May 2018 to May 2019 were selected as the cirrhosis group, and they were divided into decompensated cirrhosis complicated with peritoneal effusion group (47 cases) and non decompensated cirrhosis complicated with peritoneal effusion group (73 cases),80 patients with chronic hepatitis B diagnosed and treated at the same time were taken as the hepatitis group and 60 healthy persons as the control group.The expression of serum IBSP was detected by enzyme-linked immunosorbent assay, and the expression of serum miR-25-3p was detected by fluorescence quantitative PCR.The levels of serum miR-25-3p and IBSP in patients with different clinical characteristics in cirrhosis group were compared.Pearson linear correlation analysis was used to analyze the correlation between serum miR-25-3p, IBSP and liver function score.Multivariate logistic regression analysis was used to analyze the risk factors of decompensated liver cirrhosis complicated with peritoneal effusion.Receiver operating curve (ROC) was used to analyze the diagnostic value of miR-25-3p,IBSP and combined detection in decompensated liver cirrhosis complicated with peritoneal effusion. Results The levels of serum miR-25-3p in liver cirrhosis group, hepatitis group and control group were 5.22±0.41,1.16±0.34, 0.92±0.32, and the levels of IBSP protein were 9.34 ±1.28ng/ml, 3.15±0.37ng/ml and 1.02±0.30ng/ml, respectively.Serum miR-25-3p and IBSP protein in liver cirrhosis group were significantly higher than those in hepatitis group（t=73.327, 42.067） and control group(t=4.238, 34.486), the differences were statistically significant(all P ＜ 0.05). The expression levels of serum miR-25-3p and IBSP protein in patients with liver cirrhosis were related to liver fibrosis, gastrointestinal bleeding and peritoneal effusion (t=10.194 ~ 34.744, all P ＜ 0.05).The expression of serum miR-25-3p and IBSP protein in patients with liver cirrhosis was positively correlated with albumin bilirubin （ALBI）score, model for end-stage liver disease(MELD) score and child Pugh score of liver cirrhosis (r= 0.457 ~ 0.584, all P ＜ 0.05). Multivariate logistic regression analysis showed that the increase of serum miR-25-3p(OR: 1.202, 95% CI: 1.059 ~ 1.642) and IBSP (OR: 1.229,95% CI: 1.081 ~ 1.719) were independent risk factors of decompensated liver cirrhosis complicated with peritoneal effusion.ROC curve showed that the area under the curve (AUC) of miR-25-3p and IBSP in the combined diagnosis of decompensated liver cirrhosis and concurrent peritoneal effusion was greater than that of miR-25-3p and IBSP alone (Z = 3.727, 4.163, all P = 0.000). Conclusion The serum levels of miR-25-3p and IBSP protein in patients with hepatitis B cirrhosis increased. The combined detection of miR-25-3p and IBSP protein has high diagnostic value for decompensated hepatitis B cirrhosis complicated with peritoneal effusion.

参考文献/References:

[1] ROEHLEN N, CROUCHET E, BAUMERT T F. Liver fibrosis: mechanistic concepts and therapeutic perspectives[J]. Cells (Basel, Switzerland), 2020, 9(4):875.
[2] 黄鸿娜, 张文富, 苏晓文, 等. 肝硬化顽固性腹水的中医治疗进展[J]. 广西中医药大学学报, 2020,23(2):55-58. HUANG Hongna, ZHANG Wenfu, SU Xiaowen, et al.Progress in TCM treatment of refractory ascites due to liver cirrhosis[J]. Journal of Guangxi University of Chinese Medicine, 2020, 23(2):55-58.
[3] KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J].Nature Reviews Gastroenterology & Hepatology, 2021,18(3): 151-166.
[4] CISILOTTO J, DO AMARAL A E, ROSOLEN D, et al. MicroRNA profiles in serum samples from Acuteon-chronic liver failure patients and miR-25-3p as a potential biomarker for survival prediction[J]. Scientific Reports, 2020, 10(1): 100.
[5] SHINTANI S, KAMAKURA N, KOBATA M, et al.Identification and characterization of integrin-binding sialoprotein (IBSP) genes in reptile and amphibian[J].Gene, 2008, 424(1-2): 11-17.
[6] BRUHA R, JACHYMOVA M, PETRTYL J, et al.Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis[J].World Journal of Gastroenterology, 2016, 22(12): 3441-3450.
[7] BENZ F, BOGEN A, PRAKTIKNJO M, et al. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis[J]. PLoS One,2020, 15(4): e0231701.
[8] 王贵强, 王福生, 成军, 等. 慢性乙型肝炎防治指南(2015 年版)[J]. 中华实验和临床感染病杂志（电子版）, 2015, 9(5): 570-589. WANG Guiqiang, WANG Fusheng, CHENG Jun,et al. The guideline of prevention and treatment for chronic hepatitis B(2015 version) [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2015,9(5):570-589.
[9] 徐小元, 丁惠国, 李文刚, 等. 肝硬化腹水及相关并发症的诊疗指南(2017, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(1):1-17. XU Xiaoyuan, DING Huiguo, LI Wengang, et al.Guidelines on the management of ascites and complications in cirrhosis（2017, Beijing）[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition),2018,5(1):1-17.
[10] 张佳佳, 杨瑞涛, 雒尧. 彩色多普勒超声在老年肝硬化门静脉高压症诊断中的价值[J]. 中国现代普通外科进展, 2020, 23（10）：828-829. ZHANG Jiajia, YANG Ruitao, LUO Yao. Value of portal hemodynamics detected by ultrasound in the diagnosis of portal hypertension in elderly patients with cirrhosis [J]. Chinese Journal of Current Advances in General Surgery,2020,23(10):828-829.
[11] 贺燕燕, 刘一品. 瞬时弹性成像联合NLR、PLR 对乙型肝炎肝硬化并发症的预测价值及与病情严重程度的关系[J]. 滨州医学院学报,2021,44(3):167-172. HE Yanyan, LIU Yipin. Predictive value of transient elastography combined with NLR and PLR for the complications of hepatitis B liver cirrhosis and its relationship with the severity of the disease [J]. Journal of Binzhou Medical University,2021,44(3):167-172.
[12] FELGENDREFF P, RASCHZOK N, KUNZE K, et al. Tissue-based miRNA mapping in alcoholic liver cirrhosis:different profiles in cirrhosis with or without hepatocellular carcinoma[J]. Biomarkers, 2020, 25(1):62-68.
[13] LOUREIRO D, TOUT I, NARGUET S, et al. MiRNAs as potential biomarkers for viral hepatitis B and C[J].Viruses, 2020, 12(12): 1440.
[14] ZENG Zhicheng, LI Yuling, PAN Yangjian, et al.Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis[J]. Nature Communications, 2018, 9(1): 5395.
[15] YAO Yulong, SUN Fangyuan, LEI Ming. MiR-25 inhibits sepsis-induced cardiomyocyte apoptosis by targetting PTEN[J]. Bioscience Reports, 2018, 38(2):1511-1523.
[16] JIN Hui, LI Chunxue, DONG Peihong, et al. Circular RNA cMTO1 promotes PTEN expression through sponging miR-181b-5p in liver fibrosis[J]. Frontiers in Cell and Developmental Biology, 2020, 8: 714.
[17] LABENZ C, TOENGES G, HUBER Y, et al. Raised serum interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy[J]. Alimentary Pharmacology & Therapeutics, 2019, 50(10):1112-1119.
[18] OUYANG Yi, TANG Yujing, FU Lei, et al. Exosomes secreted by chronic hepatitis B patients with PNALT and liver inflammation grade ≥ A2 promoted the progression of liver cancer by transferring miR-25-3p to inhibit the co-expression of TCF21 and HHIP[J].Cell Proliferation, 2020, 53(7): 12833.
[19] WIDJAJA A A, SINGH B K, ADAMI E, et al.Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis[J].Gastroenterology, 2019, 157(3): 777-792, e14.
[20] WANG Shuang, SASAKI Y, ZHOU Liming, et al.Transcriptional regulation of bone sialoprotein gene by interleukin-11[J]. Gene, 2011, 476(1/2): 46-55.
[21] WANG Dong, WANG Xiaohui, SI Mahan, et al.Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J].Cancer Letters, 2020, 474(5): 36-52.
[22] 沈海涛, 焦荣红, 陆志成, 等. 原发性肝癌患者外周血CD39+,CD73+ 调节性T 细胞和自然杀伤(NK) 细胞的表达及其与肝损伤的相关性[J]. 现代检验医学杂志, 2019, 34(1):10-13. SHEN Haitao, JIAO Ronghong, LU Zhicheng, et al.Correlation between the expression of peripheral blood CD39+ and CD73+ in regulatory T cells and nature kill cell in patients with hepatocellular carcinoma and liver injury [J]. Journal of Modern Laboratory Medicine,2019, 34(1):10-13.
[23] NAYAK S, DEY T, NASKAR D, et al. The promotion of osseointegration of titanium surfaces by coating with silk protein sericin[J]. Biomaterials, 2013,34(12):2855-2864.
[24] ZARE-CHAHOKI A, AHMADI-ZEIDABADI M,AZADARMAKI S, et al. Inflammation in an animal model of multiple sclerosis leads to MicroRNA-25-3p dysregulation associated with inhibition of Pten and Klf4[J]. Iran J Allergy Asthma Immuno, 2021,20(3):314-325.

相似文献/References:

[1]杨渝伟,黄玉霞,陈小红,等.胱抑素C及其eGFR方程在诊断肝硬化患者肾损害中的应用[J].现代检验医学杂志,2016,31(04):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
　YANG Yu-wei,HUANG Yu-xia,CHEN Xiao-hong,et al.Clinical Application of Cystatin C and It's eGFR Equation for Diagnosing Kidney Injure in Patients with Liver Cirrhosis[J].Journal of Modern Laboratory Medicine,2016,31(04):24.[doi:10.3969/j.issn.16717-414.2016.04.006]
[2]薛 姣,肖海峰,姜南艳,等.肝硬化患者血浆胆碱酯酶活性对麻醉剂米库氯铵代谢的影响[J].现代检验医学杂志,2019,34(05):124.[doi:10.3969/j.issn.1671-7414.2019.05.030]
　XUE Jiao,XIAO Hai-feng,JIANG Nan-yan,et al.Effects of Plasma Cholinesterase Activity on the Metabolism of Mivacurium(Anesthetic)in Patients with Hepatocirrhosis[J].Journal of Modern Laboratory Medicine,2019,34(04):124.[doi:10.3969/j.issn.1671-7414.2019.05.030]
[3]刘昌贺,李　衡,徐圣杰,等.肝硬化伴肝性脑病与血清IL-6表达水平相关性的meta分析[J].现代检验医学杂志,2022,37(03):56.[doi:10.3969/j.issn.1671-7414.2022.03.012]
　LIU Chang-he,LI Heng,XU Sheng-jie,et al.Meta Analysis of the Correlation between Serum Interleukin-6 and Hepatic Encephalopathy in Liver Cirrhosis[J].Journal of Modern Laboratory Medicine,2022,37(04):56.[doi:10.3969/j.issn.1671-7414.2022.03.012]
[4]冯 瑾,魏绪仓.肝硬化患者骨髓造血系统异常的机制研究进展及其骨髓细胞学检查的临床意义[J].现代检验医学杂志,2023,38(02):200.[doi:10.3969/j.issn.1671-7414.2023.02.038 ]
　FENG Jin,WEI Xu-cang.Research Progress on the Mechanism of Bone Marrow Hematopoietic System Abnormalities in Patients with Liver Cirrhosis and Its Clinical Significance of Bone Marrow Cytology[J].Journal of Modern Laboratory Medicine,2023,38(04):200.[doi:10.3969/j.issn.1671-7414.2023.02.038 ]
[5]武 倩,李 英,马燕粉,等.丙型肝炎肝硬化患者进展为肝细胞肝癌预测模型建立及验证[J].现代检验医学杂志,2024,39(05):6.[doi:10.3969/j.issn.1671-7414.2024.05.002]
　WU Qian,LI Ying,MA Yanfen,et al.Establishment and Validation of Prediction Model for Hepatocellular Carcinoma Progression in Patients with Hepatitis C Cirrhosis[J].Journal of Modern Laboratory Medicine,2024,39(04):6.[doi:10.3969/j.issn.1671-7414.2024.05.002]

备注/Memo

备注/Memo:
作者简介：赵佳慧(1990-)，女，本科，主管技师，研究方向：肝硬化相关，E-mail:zhaojiah5235642@163.com。
更新日期/Last Update: 1900-01-01